Rossix.blue.jpg
Home Products About Us Contact
P1040750.JPG

Chromogenic Kits

Learn more about our Chromogenic Kits.

Phospholipid Emulsions

Our highly stable phospholipid emulsions are suitable for use in analyses related to procoagulant and anticoagulant pathways.

References

Tris BSA

Tris 10% BSA - Stock Solution

REF TB035 (vials á 50 mL)

REF TB035 - 100 (vials á 100 mL)

Dilute 1 + 9 with water before use.

Diluted buffer fulfils the Ph Eur requirements on a coagulation Factor VIII diluent.

Composition - Stock Solution

0.5 mol/L Tris.HCl pH 7.3 (at 20°C), 2 mol/L NaCl, 10% BSA

Tris 2% BSA - Stock Solution

REF TB031

Available as package of 6 x 20 mL

Dilute 1 + 9 with water before use.

Composition - Stock Solution

0.5 mol/L Tris.HCl pH 7.3 (at 20°C), 2 mol/L NaCl, 2% BSA

Back

News

2018-06-29 Posters at the SSC meeting in Dublin July 18-21, 2018.

Steffen Rosén and Rossix AB will present two posters at the SSC meeting in Dublin:

PB229 - Overestimation of recombinant wild type FIX potency by a one-stage method indicated from comparison with a chromogenic FXIa and TF/FVIIa based methods and through discrepant activation of rwtFIX and plasma derived FIX by plasma kallikrein.

PB238 - Underassignment of FIX potency of rFIX-Albumin fusion protein by one-stage methods demonstrated in studies on FXIa and FIXa generation. 

  

2016-06-22 Publication in collaboration with NovoNordisk

Rosén P, Rosén S, Ezban M, Persson E.

Overestimation of N-glycoPEGylated factor IX activity in one-stage factor IX clotting assay owing to silica-mediated premature conversion to activated factor IX.

J Thromb Haemost 2016; 14: 1420-7.

  

2015-04-13 Publication in collaboration with AstraZeneca

Ann Lövgren et al. Blood Coagulation and Fibrinolysis, Characterization of thrombin derived from 

human recombinant prothrombin.

Open access: click here

  

Search